Reports for PFIZER CANADA ULC
Company Name
PFIZER CANADA ULC
Totals |
||
Shortage reports |
828 |
|
| Actual shortage: | 51 (6%) | |
| Anticipated shortage: | 12 (1%) | |
| Avoided shortage: | 52 (6%) | |
| Resolved: | 713 (86%) | |
Discontinuation Reports |
92 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 91 (99%) | |
| Reversed: | 1 (1%) | |
Late reports |
23 (3%) |
|
Overdue reports |
26 (41%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| DOCETAXEL INJECTION USP | 10.0MG | SOLUTION | Resolved | 2020-03-06 | 2020-03-27 | 107943 |
| DOCETAXEL INJECTION USP | 10MG | SOLUTION | Resolved | 2024-03-22 | 2024-04-26 | 223128 |
| DOCETAXEL INJECTION USP | 10MG | SOLUTION | Anticipated shortage | 2025-05-07 | 2025-05-07 | 256814 |
| DOSTINEX | 0.5MG | TABLET | Resolved | 2024-09-25 | 2024-10-21 | 238507 |
| DOSTINEX | 0.5MG | TABLET | Resolved | 2019-01-25 | 2019-09-10 | 73569 |
| DOSTINEX | 0.5MG | TABLET | Resolved | 2019-10-09 | 2019-12-21 | 95815 |
| DOSTINEX | 0.5MG | TABLET / TABLETTE | Resolved | 2017-03-13 | 2017-04-28 | 2039 |
| DOSTINEX | 0.5MG | TABLET | Resolved | 2018-03-05 | 2018-03-08 | 41789 |
| DOSTINEX | 0.5MG | TABLET | Resolved | 2018-11-06 | 2018-11-22 | 66323 |
| DOSTINEX | 0.5MG | TABLET | Resolved | 2018-11-26 | 2018-12-21 | 67675 |
| DOXORUBICIN | 2MG | SOLUTION | Resolved | 2018-02-21 | 2019-05-02 | 40515 |
| DOXORUBICIN | 2MG | SOLUTION | Resolved | 2023-07-26 | 2023-09-12 | 200032 |
| DOXORUBICIN HYDROCHLORIDE FOR INJECTION USP | 50MG | POWDER FOR SOLUTION | Resolved | 2023-07-20 | 2023-09-14 | 199246 |
| DUAVIVE | 0.45MG 20MG | TABLET (IMMEDIATE AND EXTENDED RELEASE) | Resolved | 2020-05-13 | 2023-06-27 | 114978 |
| DUAVIVE | 20MG 0.45MG | TABLET (IMMEDIATE AND EXTENDED RELEASE) | Resolved | 2024-05-30 | 2024-07-12 | 229180 |
| DUAVIVE | 20MG 0.45MG | TABLET (IMMEDIATE AND EXTENDED RELEASE) | Resolved | 2024-07-25 | 2024-08-09 | 233656 |
| DUAVIVE | 20MG 0.45MG | TABLET (IMMEDIATE AND EXTENDED RELEASE) | Resolved | 2024-08-19 | 2025-01-23 | 235491 |
| ELELYSO | 200UNIT | POWDER FOR SOLUTION | Resolved | 2024-07-26 | 2025-05-09 | 233801 |
| EPHEDRINE SULFATE INJECTION USP | 50MG | SOLUTION | Resolved | 2017-03-13 | 2019-03-30 | 1218 |
| EPINEPHRINE INJECTION USP | 1MG | SOLUTION | Resolved | 2018-01-10 | 2018-05-02 | 35670 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP | 500MG | POWDER FOR SOLUTION | Discontinued | 2021-06-09 | 2021-06-09 | 140591 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2018-08-14 | 2018-08-15 | 58099 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2018-08-14 | 2018-08-15 | 58096 |
| VIRACEPT | 625MG | TABLET TABLET | Discontinued | 2021-09-03 | 2021-10-29 | 145167 |
| VIRACEPT -250MG | 250MG | TABLET | Discontinued | 2021-09-03 | 2022-05-30 | 145163 |
| VIZIMPRO | 30MG | TABLET | Discontinued | 2023-01-13 | 2023-01-14 | 180953 |
| VIZIMPRO | 45MG | TABLET | Discontinued | 2023-01-13 | 2023-01-14 | 180956 |
| VIZIMPRO | 15MG | TABLET | Discontinued | 2023-01-13 | 2023-01-14 | 180950 |
| ZITHROMAX | 250MG | TABLET | Discontinued | 2024-08-15 | 2024-08-16 | 235326 |
| ZITHROMAX | 250MG | TABLET | Discontinued | 2024-08-15 | 2024-08-16 | 235329 |
| ZOLEDRONIC ACID FOR INJECTION | 4MG | SOLUTION | Discontinued | 2021-04-16 | 2021-04-17 | 137600 |
| ZYVOXAM 600 MG | 600MG | TABLET | Discontinued | 2020-01-17 | 2022-01-17 | 103480 |